Dr. Dan Taliaferro Brody, MD

Dr. Brody practices at Capitol SC in Washington, District of Columbia.

Dr. Brody's NPI, 1376606624, was assigned on December 18, 2006. Dr. Brody graduated from University of Maryland School of Medicine - Baltimore in 1992. Dr. Brody holds District of Columbia license MD30725.

Dr. Brody's primary practice is Capitol SC, at 2021 K Nw St, Washington, DC 20006 in District Of Columbia County. The practice phone is (202) 423-7825.

Dr. Brody's primary practice is Capitol SC in Washington, District of Columbia. The medical group on file is DMV Allergy and Asthma Center. Dmand AI also links Dr. Brody to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brody practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Brody's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Brody is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Brody's licenses on file in 2 states: District of Columbia and Maryland.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies and hives among the conditions Dr. Brody treats.

CMS data shows 7,030 Medicare services from Dr. Brody across 18 procedure codes in 2024, for 383 Medicare patients. Medicare paid $151,122 for them. Every service was in an office.

CMS counts 383 Medicare patients who saw Dr. Brody in 2024. The largest group is 75 to 84, with 186 patients. 70% of them have high cholesterol, and 55% have asthma. 3% are also on Medicaid. Their average risk score is 0.77, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brody's median patient age at 46, with 61% women.

In 2024, Dr. Brody wrote 1,532 Medicare Part D claims for 249 patients. 61% of them were for generic drugs. CMS names the drug for 1,386 of them, across 32 drugs with 11 or more claims each, at $379,270 in total drug cost. In 2023, CMS named 851 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 25 out of 100 for Dr. Brody for performance year 2024, reported individually. Dr. Brody accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Brody. Dr. Brody's most frequent co-author is Stefano Luccioli, MD.

CMS Open Payments shows 402 general payments to Dr. Brody from 29 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,724.

Dmand AI lists 4 awards for Dr. Brody, most recently Top Doctors:Washington-Baltimore in 2012.

Dr. Brody graduated from University of Maryland School of Medicine - Baltimore in 1992. Dr. Brody is a member of AAAAI.

Dr. Brody is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.